K Noda

822 total citations
45 papers, 636 citations indexed

About

K Noda is a scholar working on Epidemiology, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, K Noda has authored 45 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Oncology and 13 papers in Obstetrics and Gynecology. Recurrent topics in K Noda's work include Endometrial and Cervical Cancer Treatments (12 papers), Cervical Cancer and HPV Research (12 papers) and Cancer therapeutics and mechanisms (6 papers). K Noda is often cited by papers focused on Endometrial and Cervical Cancer Treatments (12 papers), Cervical Cancer and HPV Research (12 papers) and Cancer therapeutics and mechanisms (6 papers). K Noda collaborates with scholars based in Japan, United States and United Kingdom. K Noda's co-authors include Nagahiro Saijo, A Yajima, Hiroshi Hoshiai, Kiyoyuki Furuse, Hiromichi Hemmi, Yoh Watanabe, Minoru Koi, Hideo Kunitoh, Yuichi Kurita and Noriyuki Katsumata and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

K Noda

44 papers receiving 598 citations

Peers

K Noda
Hyung Bae Moon South Korea
Yoo‐Kyung Lee South Korea
Rainer Lehner Austria
Cláudio Galleano Zettler Brazil
Mohammad Arafa Egypt
Sheldon Weiner United States
Tapio Kuoppala Finland
Yaning Yang China
Hiroshi Tanabe Japan
K Masubuchi Japan
Hyung Bae Moon South Korea
K Noda
Citations per year, relative to K Noda K Noda (= 1×) peers Hyung Bae Moon

Countries citing papers authored by K Noda

Since Specialization
Citations

This map shows the geographic impact of K Noda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Noda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Noda more than expected).

Fields of papers citing papers by K Noda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Noda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Noda. The network helps show where K Noda may publish in the future.

Co-authorship network of co-authors of K Noda

This figure shows the co-authorship network connecting the top 25 collaborators of K Noda. A scholar is included among the top collaborators of K Noda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Noda. K Noda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugiyama, Toru, Keiichi Fujiwara, Yasuo Ohashi, et al.. (2014). Phase III placebo-controlled double-blind randomized trial of radiotherapy for stage IIB–IVA cervical cancer with or without immunomodulator Z-100: a JGOG study. Annals of Oncology. 25(5). 1011–1017. 21 indexed citations
2.
Matsumoto, Koji, Nobuo Yaegashi, Takashi Iwata, et al.. (2014). Monitoring the Impact of a National HPV Vaccination Program in Japan (MINT Study): Rationale, Design and Methods. Japanese Journal of Clinical Oncology. 44(10). 1000–1003. 8 indexed citations
3.
Aoki, Daisuke, Noriyuki Katsumata, Toru Nakanishi, et al.. (2010). A Phase II Clinical Trial of Topotecan in Japanese Patients with Relapsed Ovarian Carcinoma. Japanese Journal of Clinical Oncology. 41(3). 320–327. 5 indexed citations
4.
Kunitoh, Hideo, Tetsutaro Tamura, Taro Shibata, et al.. (2009). A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). British Journal of Cancer. 100(3). 464–469. 49 indexed citations
5.
6.
Katsumata, Noriyuki, K Noda, Shunsuke Nozawa, et al.. (2005). Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study. British Journal of Cancer. 93(9). 999–1004. 33 indexed citations
7.
Kobayashi, Kunihiko, M. Fukuoka, Kenji Takeuchi, et al.. (2002). Phase I studies of nogitecan hydrochloride for Japanese. International Journal of Clinical Oncology. 7(3). 177–186. 7 indexed citations
8.
Watanabe, Y., Hiroshi Hoshiai, Hitoshi Ueda, et al.. (2002). Low-dose mitomycin C, etoposide, and cisplatin for invasive vulvar Paget's disease. International Journal of Gynecological Cancer. 12(3). 304–307. 13 indexed citations
9.
Saito, Junko, Hiroshi Hoshiai, & K Noda. (2000). Type of Human Papillomavirus and Expression of p53 in Elderly Women with Cervical Cancer. Gynecologic and Obstetric Investigation. 49(3). 190–193. 9 indexed citations
10.
Katsumata, Noriyuki, Ryuichiro Tsunematsu, Kenichi Tanaka, et al.. (2000). A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: A Japanese Cooperative Study. Annals of Oncology. 11(12). 1531–1536. 37 indexed citations
11.
Fujiwara, Keiichi, Ichiro Kohno, Katsuaki Tanaka, et al.. (1999). Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group.. PubMed. 19(1B). 639–44. 7 indexed citations
12.
Yoshikawa, Hiroyuki, Chisato Nagata, K Noda, et al.. (1999). Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan. British Journal of Cancer. 80(3-4). 621–624. 37 indexed citations
13.
Nagata, Chisato, Hiroyuki Shimizu, Hiroyuki Yoshikawa, et al.. (1999). Serum carotenoids and vitamins and risk of cervical dysplasia from a case–control study in Japan. British Journal of Cancer. 81(7). 1234–1237. 34 indexed citations
14.
Yokoyama, Akira, Yuichi Kurita, Nagahiro Saijo, et al.. (1998). Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer. British Journal of Cancer. 78(2). 257–262. 38 indexed citations
15.
Kunitoh, Hideo, Nagahiro Saijo, Kiyoyuki Furuse, K Noda, & Makoto Ogawa. (1998). Neuromuscular toxicities of paclitaxel 210 mg m-2 by 3-hour infusion. British Journal of Cancer. 77(10). 1686–1688. 24 indexed citations
16.
Oshita, Fumihiro, K Noda, Yutaka Nishiwaki, et al.. (1997). Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer.. Journal of Clinical Oncology. 15(1). 304–309. 44 indexed citations
17.
Noda, K, et al.. (1992). Perinatal Management of Twin Pregnancy. Acta geneticae medicae et gemellologiae twin research. 41(2-3). 149–153. 2 indexed citations
18.
Noda, K, et al.. (1992). Twin Umbilical Cord Blood Gas Values. Acta geneticae medicae et gemellologiae twin research. 41(2-3). 137–142. 3 indexed citations
19.
Okamura, K., et al.. (1989). Adjuvant immunotherapy: two randomized controlled studies of patients with cervical cancer. Biomedicine & Pharmacotherapy. 43(3). 177–181. 13 indexed citations
20.
Iwasa, Shinichi, et al.. (1982). [Fundamental and clinical studies of ceftizoxime in obstetrical and gynecological field].. PubMed. 35(9). 2252–76. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyung Bae Moon Breakdown of academic impact, for papers by Yoo‐Kyung Lee Breakdown of academic impact, for papers by Rainer Lehner Breakdown of academic impact, for papers by Cláudio Galleano Zettler Breakdown of academic impact, for papers by Mohammad Arafa Breakdown of academic impact, for papers by Sheldon Weiner Breakdown of academic impact, for papers by Tapio Kuoppala Breakdown of academic impact, for papers by Yaning Yang Breakdown of academic impact, for papers by Hiroshi Tanabe Breakdown of academic impact, for papers by K Masubuchi
Rankless by CCL
2026